Shawn Wettig receives funding for research to fine-tune prostate cancer treatment using irradiated gold nanoparticles

Shawn Wettig, CBB member and Pharmacy Professor received funding from the Ride for Dad foundation who has committed $104,000 to help Wettig and his collaborators fine-tune a treatment that utilizes irradiated gold nanoparticles to target prostate cancer - one the most common cancer among Canadian men. The goal is to shorten treatment duration and reduce side effects, by delivering a more targeted treatment at a lower dose. [Science News]